TG Therapeutics

1 follower

‌

TG Therapeutics is a fully-integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

Industries

Biotechnology

Headquarters

New York, United States

Employees

201-500

Links

Org chart

Michael S. Weiss

Chairman, President, & CEO

Michael S. Weiss

Collapse

Adam Waldman

Chief Commercialization Officer

Sean A. Power

Chief Financial Officer

Mary Campos

Vice President, Head Of Human Resources

Jun Zhao

Chief Quality Officer

George Avgerinos

SVP Biologics Operations

Jenna Bosco

Senior Vice President Corporate Communications

Art Faulkner

Senior Vice President, Regulatory CMC At TG Therapeutics, Inc.

Hari Miskin

Chief Development Officer

Dana Nestinger

Sr. Director, Patient Support

Marissa Villapiano

Director, Access Marketing

Jackie Parker

Vp, Clinical Operations And PV

Emmanuel Normant

Vice President Preclinical Translational Sciences

Zachary Dana

Medical Manager

Laura Barganier

Medical Science Liaison

Matt Sutliff

Medical Science Liaison

Brian McCarthy

Executive Director, Head Of Healthcare Compliance

Sherri Bush

Clinical Science Liaison

Teams

+24

Key Account Management

27 members

+12

Leadership Team

15 members

Commercial Operations

9 members

Similar companies

Xencor

1 follower

Natera

13 followers

UNITY Biotechnology

12 followers

NeoGenomics

8 followers

Spark Therapeutics

7 followers

Idexx Laboratories

7 followers

Legend Biotech

5 followers

Denali Therapeutics

5 followers

Merck

213 followers

AbbVie

176 followers

Quanterix

3 followers

Explore companies